(VEVE) Vanguard FTSE Developed - Ratings and Ratios
Global, Large-Cap, Developed, World, Equity
Description: VEVE Vanguard FTSE Developed
The Vanguard FTSE Developed World UCITS ETF (VEVE) is a globally diversified equity exchange-traded fund that tracks the Morningstar Global TME NR USD index, providing broad exposure to large-cap stocks across developed markets. As a Netherlands-originated ETF, it is designed to offer investors a low-cost, efficient way to gain access to a wide range of international equities.
From a technical analysis perspective, VEVEs recent price action indicates a bullish trend, with the last price of 99.60 sitting above the 20-day Simple Moving Average (SMA) of 98.80 and the 50-day SMA of 94.74. The 200-day SMA at 99.04 is just below the current price, suggesting a potential resistance level. The Average True Range (ATR) of 1.12, or 1.13%, indicates moderate volatility. Given the current technical setup, a potential forecast is that VEVE may continue its upward trajectory, potentially testing the 52-week high of 107.29, although a pullback to the 200-day SMA is also possible.
Fundamentally, the ETF has a substantial Assets Under Management (AUM) of 3436.02 million EUR, indicating a high level of investor confidence and liquidity. The underlying index, Morningstar Global TME NR USD, is a widely followed benchmark for global equities. As the global economy continues to evolve, VEVEs diversified portfolio is likely to be influenced by various macroeconomic factors, including interest rates, GDP growth, and geopolitical events. Based on the current fundamental data, a forecast is that VEVEs AUM will continue to grow, driven by increasing demand for diversified global equity exposure, potentially leading to a further increase in the ETFs price.
Combining both technical and fundamental analysis, a potential trading strategy for VEVE could involve monitoring the ETFs price action around the 200-day SMA, while also keeping a close eye on macroeconomic trends and their potential impact on global equities. If the bullish trend continues, investors may consider buying on dips, targeting the 52-week high. Conversely, if the price falls below the 200-day SMA, it may be a signal to reevaluate the position or consider taking profits.
Additional Sources for VEVE ETF
VEVE ETF Overview
Market Cap in USD | 4,054m |
Category | Global Large-Cap Blend Equity |
TER | 0.12% |
IPO / Inception | 2014-09-30 |
VEVE ETF Ratings
Growth Rating | 65.7 |
Fundamental | - |
Dividend Rating | 54.2 |
Rel. Strength | -8.92 |
Analysts | - |
Fair Price Momentum | 95.67 EUR |
Fair Price DCF | - |
VEVE Dividends
Dividend Yield 12m | 1.50% |
Yield on Cost 5y | 2.70% |
Annual Growth 5y | 7.76% |
Payout Consistency | 89.9% |
Payout Ratio | % |
VEVE Growth Ratios
Growth Correlation 3m | 76.6% |
Growth Correlation 12m | 30% |
Growth Correlation 5y | 89.4% |
CAGR 5y | 12.40% |
CAGR/Max DD 5y | 0.59 |
Sharpe Ratio 12m | 0.40 |
Alpha | -6.85 |
Beta | 0.737 |
Volatility | 9.55% |
Current Volume | 0.6k |
Average Volume 20d | 0.6k |
As of July 03, 2025, the stock is trading at EUR 98.74 with a total of 644 shares traded.
Over the past week, the price has changed by +0.71%, over one month by +1.51%, over three months by +2.19% and over the past year by +5.77%.
Yes. Based on ValueRay's Analyses, Vanguard FTSE Developed (AS:VEVE) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.69 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VEVE is around 95.67 EUR . This means that VEVE is currently overvalued and has a potential downside of -3.11%.
Vanguard FTSE Developed has no consensus analysts rating.
According to our own proprietary Forecast Model, VEVE Vanguard FTSE Developed will be worth about 109.6 in July 2026. The stock is currently trading at 98.74. This means that the stock has a potential upside of +10.97%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 109.6 | 11% |